| Summary: | O Autor medicou 24 crianças portadoras de poliverminoses, com idades entre 8 a 14 anos, todas do sexo feminino, com Mebendazole (suspensão), na dose de 5 ml (100 mg) duas vezes por dia e durante três dias consecutives. O diagnóstico e o controle de cura parasitológica foram realizados pelas técnicas de Lutz, Willis, Baerman-Moraes e Graham, antes e no 7.°, 14.° e 21.° dias após o tratamento para as três primeiras, enquanto a última foi executada durante sete dias consecutivos a partir do sétimo dia de encerrada a terapêutica. Verificou cura parasitológica em 100% dos casos para ascariase e enterobiase, 69,2% para tricocefalíase, 36,36% para ancilostomíase e 0% para estrongiloidiase. Nenhuma manifestação colateral foi relatada pelos doentes. The Author reports the therapeutic activity of a new anthelmintic drug - Mebendazole suspension, in the treatment of twenty-four children, aged from 8 to 14 years-old, all females, with multiple intestinal parasitic infections. Mebendazole (suspension) was given in a dose of 5 ml (100 mg) two times per day (taken all at a morning after breakfast, and night after dinner), for three consecutives days. The diagnosis and the control laboratory data were made before the medication, and repeated 7th, 14th, 21th days after its completion and consisting of Lutz, Willis and Baerman-Moraes methods, and the anal swab technique was made for seven consecutives days, beginning the 7th day after completion of treatment. The percentual of parasitological cure rate obtained was the following: 100% for Ascaris lumbricoides and Enterobius vermicularis; 69,2% for Trichuris trichiura; 36,36% for Ancylostomidae sp and 0% for Strongyloides stercoralis. The drug under observation did not produce any side-affects.
|
|---|